132 related articles for article (PubMed ID: 20453658)
21. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
[TBL] [Abstract][Full Text] [Related]
22. Serotonin 5-HT2A receptor gene variants influence antidepressant response to repeated total sleep deprivation in bipolar depression.
Benedetti F; Barbini B; Bernasconi A; Fulgosi MC; Colombo C; Dallaspezia S; Gavinelli C; Marino E; Pirovano A; Radaelli D; Smeraldi E
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1863-6. PubMed ID: 18801406
[TBL] [Abstract][Full Text] [Related]
23. Genetic studies of drug response and side effects in the STAR*D study, part 1.
Garriock HA; Hamilton SP
J Clin Psychiatry; 2009 Aug; 70(8):1186-7. PubMed ID: 19758527
[No Abstract] [Full Text] [Related]
24. Orphan nuclear receptor Rev-erb alpha gene (NR1D1) and fluvoxamine response in major depressive disorder in the Japanese population.
Kishi T; Kitajima T; Ikeda M; Yamanouchi Y; Kinoshita Y; Kawashima K; Okochi T; Ozaki N; Iwata N
Neuropsychobiology; 2009; 59(4):234-8. PubMed ID: 19571598
[TBL] [Abstract][Full Text] [Related]
25. Association between the 5-HT6 receptor C267T polymorphism and response to antidepressant treatment in major depressive disorder.
Lee SH; Lee KJ; Lee HJ; Ham BJ; Ryu SH; Lee MS
Psychiatry Clin Neurosci; 2005 Apr; 59(2):140-5. PubMed ID: 15823158
[TBL] [Abstract][Full Text] [Related]
26. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
Mouchabac S; Ferreri M; Cabanac F; Bitton M
Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
[TBL] [Abstract][Full Text] [Related]
27. Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment.
Liou YJ; Chen TJ; Tsai SJ; Yu YW; Cheng CY; Hong CJ
Pharmacogenet Genomics; 2009 Oct; 19(10):735-41. PubMed ID: 19741570
[TBL] [Abstract][Full Text] [Related]
28. Augmentation of antidepressants with perospirone for treatment-resistant major depressive disorder.
Sato Y; Yasui-Furukori N; Nakagami T; Saito M; Kaneko S
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):416-8. PubMed ID: 19166896
[TBL] [Abstract][Full Text] [Related]
29. Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in major depression.
Domschke K; Dannlowski U; Ohrmann P; Lawford B; Bauer J; Kugel H; Heindel W; Young R; Morris P; Arolt V; Deckert J; Suslow T; Baune BT
Eur Neuropsychopharmacol; 2008 Oct; 18(10):751-9. PubMed ID: 18579347
[TBL] [Abstract][Full Text] [Related]
30. RGS4 polymorphism and response to electroconvulsive therapy in major depressive disorder.
Huuhka K; Kampman O; Anttila S; Huuhka M; Rontu R; Mattila KM; Hurme M; Lehtimäki T; Leinonen E
Neurosci Lett; 2008 May; 437(1):25-8. PubMed ID: 18434012
[TBL] [Abstract][Full Text] [Related]
31. Association between the tryptophan hydroxylase-1 gene A218C polymorphism and citalopram antidepressant response in a Korean population.
Ham BJ; Lee BC; Paik JW; Kang RH; Choi MJ; Choi IG; Lee MS
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):104-7. PubMed ID: 16979275
[TBL] [Abstract][Full Text] [Related]
32. Failure to replicate genetic associations with antidepressant treatment response in duloxetine-treated patients.
Perlis RH; Fijal B; Dharia S; Heinloth AN; Houston JP
Biol Psychiatry; 2010 Jun; 67(11):1110-3. PubMed ID: 20110084
[TBL] [Abstract][Full Text] [Related]
33. Association between 5-hydroxytryptamine 1A receptor gene polymorphism and suicidal behavior.
Sawiniec J; Borkowski K; Ginalska G; Lewandowska-Stanek H
Przegl Lek; 2007; 64(4-5):208-11. PubMed ID: 17724868
[TBL] [Abstract][Full Text] [Related]
34. Antidepressant response and subthreshold bipolarity in "unipolar" major depressive disorder: implications for practice and drug research.
Rihmer Z; Dome P; Gonda X
J Clin Psychopharmacol; 2013 Aug; 33(4):449-52. PubMed ID: 23775059
[No Abstract] [Full Text] [Related]
35. Further Support for the Involvement of Genetic Variants Related to the Serotonergic Pathway in the Antidepressant Response in Children and Adolescents After a 12-Month Follow-Up: Impact of the
Gassó P; Blázquez A; Rodríguez N; Boloc D; Torres T; Mas S; Lafuente A; Lázaro L
J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):711-718. PubMed ID: 29975559
[No Abstract] [Full Text] [Related]
36. A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders.
Gratacòs M; Soria V; Urretavizcaya M; González JR; Crespo JM; Bayés M; de Cid R; Menchón JM; Vallejo J; Estivill X
Pharmacogenomics J; 2008 Apr; 8(2):101-12. PubMed ID: 17505499
[TBL] [Abstract][Full Text] [Related]
37. Identifying patients with therapy-resistant depression by using factor analysis.
Andreasson K; Liest V; Lunde M; Martiny K; Unden M; Dissing S; Bech P
Pharmacopsychiatry; 2010 Nov; 43(7):252-6. PubMed ID: 20821367
[TBL] [Abstract][Full Text] [Related]
38. Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder.
Kang RH; Wong ML; Choi MJ; Paik JW; Lee MS
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1317-21. PubMed ID: 17618721
[TBL] [Abstract][Full Text] [Related]
39. Association between the 5-HT1A receptor gene polymorphism (rs6295) and antidepressants: a meta-analysis.
Zhao X; Huang Y; Li J; Ma H; Jin Q; Wang Y; Wu L; Zhu G
Int Clin Psychopharmacol; 2012 Nov; 27(6):314-20. PubMed ID: 22890315
[TBL] [Abstract][Full Text] [Related]
40. Investigation of serotonin-related genes in antidepressant response.
Peters EJ; Slager SL; McGrath PJ; Knowles JA; Hamilton SP
Mol Psychiatry; 2004 Sep; 9(9):879-89. PubMed ID: 15052272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
